TopoGEN News
- Home
- Blog
Accelerate Your R&D Output with the New IQ Screen
We are thrilled to announce the launch of our groundbreaking screening tool, the **IQ Screen**
Contract R&D to Identify Drugs that Target Human Topo I, Topo II, Bacterial Topo IV and DNA Gyrase
Experience. Rapid Turn-Around. Publication Quality. TopoGEN has >20 yrs. experience in the area as a Contract Research Organization and we stand behind our results. We guarantee clear, cosmetic data and unambiguous...
Cell Context DNA Repair Kits Now Available
Are you working on DNA-damage and repair? Would you be interested in a pre-validated cell-context system to analyze HR or NHEJ by single cell imaging or quantifying DNA repair by simple fluorescence? TopoGEN, Inc....
SBIR-Funded Alliance to Conquer the Cold-Chain
July 20, 2018 TopoGEN was featured in the local press in order to showcase our collaboration with Nanoly Bioscience based out of Boulder. Nanoly has developed a polymer-based cage (the NanoShield) that can protect labile...